Trial Profile
A phase I trial of anti-GITR antibody for the treatment of cancer
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 04 Mar 2016
Price :
$35
*
At a glance
- Drugs Afimetoran (Primary)
- Indications Cancer
- Focus Adverse reactions
- 04 Mar 2016 New trial record